Data / Form D filings / DERMA SCIENCES, INC.
DERMA SCIENCES, INC.: Form D filing
DERMA SCIENCES, INC., a pharmaceuticals company in Princeton, NJ, filed a Form D with the SEC in 2011. The latest, on July 5, 2011, reports $29.1 million sold of a $29.1 million offering to 18 investors.
Find out what DERMA SCIENCES, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 214 Carnegie Center, Suite 300, Princeton, NJ, 08540
- Phone
- (609) 514-4744
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Pennsylvania
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 892160
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 5, 2011 | New notice | $29,074,972 | $29,074,972 | $0 | 18 | Jun 20, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| C. Richard Stafford, Esq. | Director | |
| Bruce F. Wesson | Director | |
| John E. Yetter | Executive Officer | |
| Barry J. Wolfenson | Executive Officer | |
| Stephen T. Wills, CPA, MST | Director | |
| Edward J. Quilty | Director, Executive Officer | |
| James T. O'Brien | Director | |
| Frederic C. Eigner | Executive Officer | |
| Richard J. Keim | Director | |
| Robert G. Moussa | Director | |
| Srini T. Conjeevaram | Director | |
| Brett F. Hewlett | Director | |
| Robert C. Cole | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jul 4, 2011 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what DERMA SCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.